INTS9-AS1

Across TCGA pan-cancer cohorts, INTS9-AS1 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated INTS9-AS1 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher INTS9-AS1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated INTS9-AS1 expression acts as an unfavorable survival marker, although some lineages such as CHOL and HNSC show a favorable association.

MESO, COAD, and CHOL are the cancer types where INTS9-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	DFS	Tertile	All	0.113	0.616	.010	58	view →
COAD	DFS	Tertile	All	0.283	0.640	<.001	46	view →
CHOL	DFS	Median	All	0.667	0.183	<.001	45	view →
THCA	DFS	Median	II,III,IV	0.769	0.890	.008	37	view →
HNSC	OS	Tertile	IV	0.743	0.580	.012	31	view →
UVM	OS	Tertile	All	0.577	1.000	.007	27	view →
STAD	DFS	Median	IV	0.214	0.544	.025	15	view →
UCS	OS	Tertile	IV	1.000	0.300	.024	14	view →
SKCM	DFS	Median	IV	0.111	0.694	.004	9	view →
ACC	OS	Tertile	III,IV	0.769	0.257	.021	8	view →
LGG	DFS	Tertile	All	0.765	0.853	.004	8	view →
PRAD	OS	Quartile	All	0.750	0.917	.010	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

INTS9-AS1–MESO (DFS)

Open the MESO breakdown →